NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.46 +0.02 (+0.82%)
At close: Oct 23, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Goodwill & Intangibles (2020 - 2021)

Updated

NeuroSense Therapeutics (NRSN) reported Goodwill & Intangibles of $19,000 for Q4 2021, up 46.2% from $13,000 a year earlier.

Analysis

NeuroSense Therapeutics (NRSN) Goodwill & Intangibles (2020 - 2021) Analysis & Trends

  • By year, Goodwill & Intangibles came in at $13,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 NeuroSense Therapeutics 3.08 Mn -1.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 19,000.00
Dec 31, 2020 13,000.00
API Access

NeuroSense Therapeutics Goodwill & Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=NRSN&period=max&api_key=YOUR_API_KEY